1 active not recruiting, 1 not yet recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow Jeong Eon Lee: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial Avoiding surgery - Ductal Carcinoma in Situ of the Breast | Not applicable | Not yet recruiting | Jeong Eon Lee | 340 | 2025-12-01 | 2025-11-24 |
| Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm (ASLAN) Study avoid axillary sentinel lymph node biopsy after neoadjuvant chemotherapy - Breast Cancer | Not applicable | Active not recruiting | Jeong Eon Lee | 178 | 2021-09-27 | 2024-01-26 |
Breast Neoplasms (1) · Carcinoma, Intraductal, Noninfiltrating (1)
South Korea (2)